On Apr. 22, 2020, LabCorp announced expanded serological testing for SARS-CoV-2, the virus that causes COVID-19, to more hospitals and healthcare organizations.

The COVID-19 serological tests are in addition to the company’s existing molecular test for COVID-19 available nationwide through healthcare providers, and to healthcare workers and emergency responders through its Pixel by LabCorp at-home self-collection test kit.